Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Cisplatin and Gemcitabine in advanced NSCLC
NCT00561054Phase 2Unknown
- Sponsor
- Grupo Português de Estudo do Cancro do Pulmão
- Start
- Mar 2007
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of cetuximab in non-small cell lung cancer (NSCLC), sponsored by Grupo Português de Estudo do Cancro do Pulmão. Status: unknown.
02
Drugs
cetuximab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00561054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00561054.